Skip to main content
CKD Bio Corp. logo

CKD Bio Corp. — Investor Relations & Filings

Ticker · 063160 ISIN · KR7063160006 LEI · 988400RFJ8DLB1NTOE10 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2020-02-25 AGM Information
Country KR South Korea
Listing KO 063160

About CKD Bio Corp.

https://www.ckdbio.com/en/home

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Chong Kun Dang Bio. It contains the agenda for the upcoming Annual General Meeting (AGM), including items such as the approval of financial statements, election of directors, and dividend proposals. It also includes detailed management information, board activity reports, and financial statements (balance sheet, income statement, etc.) as part of the meeting materials provided to shareholders. This document is a standard proxy statement/notice of meeting used to solicit votes and inform shareholders of the upcoming AGM proceedings.
2020-02-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유) for the Annual General Meeting (AGM) of Chong Kun Dang Bio. It contains information about the solicitor, the purpose of the solicitation (securing quorum for the AGM), the date and location of the meeting, and the agenda items including the approval of financial statements. It is a formal document sent to shareholders to request their votes, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2020-02-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in shareholding percentage of a major shareholder (Chong Kun Dang Holdings) in a listed company (Chong Kun Dang Bio) due to the acquisition of bonus shares. This falls under the category of Major Shareholding Notification.
2020-02-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 95% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is used to disclose changes in share ownership by insiders or major shareholders. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ) as it details the change in shareholding percentage by a major shareholder (Chong Kun Dang Holdings) in the issuing company (Chong Kun Dang Bio).
2020-02-07 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Chong Kun Dang Bio. This type of filing specifically tracks changes in ownership stakes held by major shareholders and related parties, which corresponds to the 'Major Shareholding Notification' category (MRQ).
2020-02-07 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Chong Kun Dang Bio) announcing a significant change in financial results (revenue/profit structure change of 30% or more). This is a standard preliminary earnings disclosure required by the Korea Exchange (KRX) for listed companies. Since it provides key financial highlights (revenue, operating profit, net income) before the final audited annual report is released, it falls under the 'Earnings Release' category.
2020-01-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.